Literature DB >> 26359964

Evaluation of outpatient medication reconciliation involving student pharmacists at a comprehensive cancer center.

Emily Ashjian, Louise B Salamin, Katie Eschenburg, Shawna Kraft, Emily Mackler.   

Abstract

OBJECTIVE: To determine the number of discrepancies and medication-related problems found as a result of pharmacy-led medication reconciliation involving introductory pharmacy practice experience (IPPE) students at a comprehensive cancer center.
SETTING: Outpatient infusion center of a National Cancer Institute (NCI)-designated and National Comprehensive Cancer Network (NCCN) cancer center. PRACTICE DESCRIPTION AND INNOVATION: Third-year IPPE students contacted and completed medication reconciliation for 510 hematology/oncology patients scheduled for infusion center appointments without a coupled provider visit. IPPE students discussed the findings of the medication reconciliations with their pharmacist preceptors, who updated the medication histories in the electronic medical record (EMR) and communicated with prescribers directly about identified medication-related problems. All medication reconciliation was documented using a standardized note template in the EMR. MAIN OUTCOME MEASURES: Number of medication discrepancies found, including medication additions, medication deletions, dose changes, and herbal product additions; medication-related problems-including drug-drug interactions, untreated indications (e.g., nausea, vomiting, pain, need for prophylactic medications), failure of patients to receive prescribed medications, and adverse drug reactions-were also documented.
RESULTS: Medication reconciliation was completed for 510 patients through the student pharmacist/pharmacist preceptor-led intervention during a 1-year period between January 1, 2013, and December 31, 2013. A total of 88% of patients had at least one discrepancy identified in their medication history and corrected in the EMR. In addition, 11.4% of patients had a medication-related problem identified.
CONCLUSIONS: Pharmacy-led medication reconciliation identified a large number of discrepancies among our hematology/oncology patients. This intervention allowed for correction of discrepancies in the EMR leading to improved accuracy of patient medication lists. In addition, it provided a valuable learning experience for student pharmacists.

Entities:  

Mesh:

Year:  2015        PMID: 26359964     DOI: 10.1331/JAPhA.2015.14214

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  6 in total

1.  Pharmacist-led pre-treatment assessment, management and outcomes in a Hepatitis C treatment patient cohort.

Authors:  Miriam Coghlan; Aisling O'Leary; Gail Melanophy; Colm Bergin; Suzanne Norris
Journal:  Int J Clin Pharm       Date:  2019-07-11

2.  Impact of a Student Pharmacist Driven Medication Reconciliation and Antidepressant Treatment History Project at a Depression Clinic: A Pilot Study.

Authors:  Stella S Tang; Leanna Jaward; Kristen Ward; Sagar V Parikh; Jolene R Bostwick
Journal:  Psychopharmacol Bull       Date:  2017-05-15

3.  The Impact of Completing Medication Reconciliation and Depression Treatment History in an Outpatient Depression Clinic.

Authors:  Sarah J Choi; Roberta Storey; Sagar V Parikh; Jolene R Bostwick
Journal:  Psychopharmacol Bull       Date:  2019-02-15

4.  Improving Medication History at Admission Utilizing Pharmacy Students and Technicians: A Pharmacy-Driven Improvement Initiative.

Authors:  Katerina Petrov; Ranjani Varadarajan; Martha Healy; Elmira Darvish; Cathleen Cowden
Journal:  P T       Date:  2018-11

5.  2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.

Authors:  Emily Mackler; Eve M Segal; Benyam Muluneh; Kate Jeffers; Jenna Carmichael
Journal:  J Oncol Pract       Date:  2019-03-12       Impact factor: 3.840

6.  The value of incorporating patient-consulted medication reconciliation in influencing drug-related actions in the outpatient rheumatology setting.

Authors:  Denise J van der Nat; Victor J B Huiskes; Aatke van der Maas; Judith Y M N Derijks-Engwegen; Hein A W van Onzenoort; Bart J F van den Bemt
Journal:  BMC Health Serv Res       Date:  2022-08-05       Impact factor: 2.908

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.